Adipose-derived mesenchymal stem cells as local treatment of ulcerative colitis
This research is exploring a new treatment idea for ulcerative colitis, a condition that causes inflammation in the large intestine. The study uses something called 'adipose-derived mesenchymal stem cells', which are special cells taken from body fat. The aim is to inject these cells directly into the inflamed areas of the gut to see if they can help reduce the inflammation. This is a combined Phase I and Phase II study, meaning it’s looking at both the safety of the treatment and how effective it might be at improving the condition. Researchers will be checking if the treatment reduces gut inflammation and improves symptoms after treatment. This is a hopeful step towards finding new ways to manage ulcerative colitis.
At a glance
What is this study about?
Ulcerative colitis is a long-term condition where the lining of the large intestine (colon) and rectum becomes inflamed. This can lead to symptoms like tummy pain, diarrhoea, and blood in your poo. Doctors are always looking for new and better ways to help people living with this condition feel better and manage their symptoms.
This particular study is investigating a new type of treatment using 'mesenchymal stem cells' which are special cells found in your body, in this case taken from fat tissue. These cells have properties that might help reduce inflammation and repair damaged tissues. The idea is to inject these cells directly into the inflamed areas of the gut, rather than taking a tablet or injection that affects the whole body. The hope is that by targeting the problem area, the inflammation can be calmed down more effectively.
This study is in its early stages, known as Phase I and Phase II. This means doctors are carefully checking two main things: firstly, if the treatment is safe to use and doesn't cause serious side effects, and secondly, if it shows promising signs of actually working to reduce inflammation and improve symptoms in people with ulcerative colitis. They will look at the lining of the gut to see if the inflammation has reduced and also check if people feel better after the treatment.
Key takeaways
- This study is testing a new cell-based treatment for ulcerative colitis.
- It aims to reduce gut inflammation using special cells from fat tissue.
- The treatment involves injections directly into the inflamed areas of the gut.
- Researchers will check for safety and how well it reduces inflammation and improves symptoms.
- The study is in early stages (Phase I and II) and involves regular check-ups and endoscopies.
Who may be eligible?
To be considered for this study, you need to be an adult, 18 years old or older. The study is open to both men and women. There’s no upper age limit, but you will need to meet other specific health requirements that your doctor will discuss with you.
Before taking part, you would have a thorough check-up to make sure this study is right for you and that you meet all the necessary health criteria. This is to ensure your safety and that the study results are clear. Your doctor will be able to explain more about whether you might be a good fit.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of ulcerative colitis?
- Are you willing to undergo regular medical check-ups and endoscopies?
- Do you understand that you might not receive the active cell treatment?
- Are you able to commit to the study's follow-up schedule?
What does participation involve?
If you decide to take part in this study, you might receive injections of the special cells (MSC) or a salt water solution (placebo) in the inflamed area of your gut. This will be done to see how effective the cells are compared to no active treatment. You will have regular check-ups and investigations, including 'endoscopies' (where a small camera is used to look inside your gut) at 4, 7, 14, and 30 days after your treatment. During these visits, doctors will assess your inflammation, take tiny tissue samples (biopsies), and ask about your symptoms. They will also collect blood samples to see how your body reacts to the treatment. The total duration of your active participation, including follow-up, will involve these assessments over at least 30 days after the initial treatment.
Potential risks and benefits
Locations (1)
- —UnverifiedDenmark
Common questions
What are 'mesenchymal stem cells'?
These are special cells found in your body, like in fat tissue, that have the potential to repair damaged tissues and reduce inflammation.
How will the treatment be given?
The cells will be injected directly into the inflamed areas of your large intestine, likely during an endoscopy procedure.
What is an endoscopy?
An endoscopy is a procedure where a thin, flexible tube with a camera is passed into your gut to allow doctors to look at the lining and sometimes take small tissue samples.
Will I know if I'm getting the treatment or a placebo?
No, in this type of study, often neither you nor your doctor will know during the study which treatment you are receiving (either the cells or a salt water solution) to keep the results unbiased.
How long will I be involved in the study?
You will have assessments and follow-up for at least 30 days after getting the treatment.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.